Cysteamine might be a treatment for Huntington’s Disease

Huntington’s Disease is a neurological condition that can bring on intellectual deterioration, leading to dementia. It is accompanied by symptons of depression and involuntary abnormal body movements. It is a rare condition that usually occurs between the ages of 35 and 50 years, often leading to death in the following 15 to 20 years.

Researchers at the Institut Curie, CNRS and Inserm have shown that cysteamine, which is already used to treat Cystinosis, can help prevent the death of neurons in the brain and hence be used to treat Huntington’s Disase.

More on this research can be found at http://www.innovations-report.de.

Comments are closed.

Wendy Walks Again for Cystinosis Last year Wendy Exelby, whose son Adam has cystinosis, raised £400 for us by doing a sponsored [...] Read more...
National Cystinosis Study Day at QE Hospital, Birmingham The QE Hospital in Birmingham are hosting a ‘National Cystinosis Study Day’ on [...] Read more...
Derby Moor Student an Inspiration to Us All Derby Moor student Eeshar Seehra was thrilled to achieve 3 A Levels in Maths, Physics and [...] Read more...
Newsletter – November 2012 Issue 21 of the Foundation newsletter has recently been finalised and is available to download [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday